These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 28516770)

  • 1. Conjugated Polymers Act Synergistically with Antibiotics to Combat Bacterial Drug Resistance.
    Tian J; Zhang J; Yang J; Du L; Geng H; Cheng Y
    ACS Appl Mater Interfaces; 2017 Jun; 9(22):18512-18520. PubMed ID: 28516770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic activity profile of an antimicrobial peptide against multidrug-resistant and extensively drug-resistant strains of Gram-negative bacterial pathogens.
    Pollini S; Brunetti J; Sennati S; Rossolini GM; Bracci L; Pini A; Falciani C
    J Pept Sci; 2017 Apr; 23(4):329-333. PubMed ID: 28176481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibacterial activity of the recombinant antimicrobial peptide Ib-AMP4 from Impatiens balsamina and its synergy with other antimicrobial agents against drug resistant bacteria.
    Fan X; Reichling J; Wink M
    Pharmazie; 2013 Jul; 68(7):628-30. PubMed ID: 23923648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From Breast Cancer to Antimicrobial: Combating Extremely Resistant Gram-Negative "Superbugs" Using Novel Combinations of Polymyxin B with Selective Estrogen Receptor Modulators.
    Hussein MH; Schneider EK; Elliott AG; Han M; Reyes-Ortega F; Morris F; Blastovich MAT; Jasim R; Currie B; Mayo M; Baker M; Cooper MA; Li J; Velkov T
    Microb Drug Resist; 2017 Jul; 23(5):640-650. PubMed ID: 27935770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic Antimicrobial Activity Between the Broad Spectrum Bacteriocin Garvicin KS and Nisin, Farnesol and Polymyxin B Against Gram-Positive and Gram-Negative Bacteria.
    Chi H; Holo H
    Curr Microbiol; 2018 Mar; 75(3):272-277. PubMed ID: 29058043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological synergism of bee venom and melittin with antibiotics and plant secondary metabolites against multi-drug resistant microbial pathogens.
    Al-Ani I; Zimmermann S; Reichling J; Wink M
    Phytomedicine; 2015 Feb; 22(2):245-55. PubMed ID: 25765829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibacterial activity of Thymus maroccanus and Thymus broussonetii essential oils against nosocomial infection - bacteria and their synergistic potential with antibiotics.
    Fadli M; Saad A; Sayadi S; Chevalier J; Mezrioui NE; Pagès JM; Hassani L
    Phytomedicine; 2012 Mar; 19(5):464-71. PubMed ID: 22257599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic antibacterial activity of the combination of the alkaloid sanguinarine with EDTA and the antibiotic streptomycin against multidrug resistant bacteria.
    Hamoud R; Reichling J; Wink M
    J Pharm Pharmacol; 2015 Feb; 67(2):264-73. PubMed ID: 25495516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gold Nanoparticles with Antibiotic-Metallopolymers toward Broad-Spectrum Antibacterial Effects.
    Yang P; Pageni P; Rahman MA; Bam M; Zhu T; Chen YP; Nagarkatti M; Decho AW; Tang C
    Adv Healthc Mater; 2019 Mar; 8(6):e1800854. PubMed ID: 30480381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibacterial and antibiotic-resistance modifying activity of the extracts and compounds from Nauclea pobeguinii against Gram-negative multi-drug resistant phenotypes.
    Seukep JA; Sandjo LP; Ngadjui BT; Kuete V
    BMC Complement Altern Med; 2016 Jul; 16():193. PubMed ID: 27386848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial Peptide Novicidin Synergizes with Rifampin, Ceftriaxone, and Ceftazidime against Antibiotic-Resistant Enterobacteriaceae In Vitro.
    Soren O; Brinch KS; Patel D; Liu Y; Liu A; Coates A; Hu Y
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6233-40. PubMed ID: 26248380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of Gram-negative bacterial infections by potentiation of antibiotics.
    Zabawa TP; Pucci MJ; Parr TR; Lister T
    Curr Opin Microbiol; 2016 Oct; 33():7-12. PubMed ID: 27232956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The history of the development and changes of quinolone antibacterial agents].
    Takahashi H; Hayakawa I; Akimoto T
    Yakushigaku Zasshi; 2003; 38(2):161-79. PubMed ID: 15143768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of novel in silico-developed antimicrobial peptides against a panel of bacterial pathogens.
    Romani AA; Baroni MC; Taddei S; Ghidini F; Sansoni P; Cavirani S; Cabassi CS
    J Pept Sci; 2013 Sep; 19(9):554-65. PubMed ID: 23893489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibiotics-Peptide Conjugates Against Multidrug-resistant Bacterial Pathogens.
    David AA; Park SE; Parang K; Tiwari RK
    Curr Top Med Chem; 2018; 18(22):1926-1936. PubMed ID: 30499392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibacterial activity of conjugated polyelectrolytes with variable chain lengths.
    Ji E; Parthasarathy A; Corbitt TS; Schanze KS; Whitten DG
    Langmuir; 2011 Sep; 27(17):10763-9. PubMed ID: 21739989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial peptides as promising antibiotic adjuvants to combat drug-resistant pathogens.
    Chen C; Shi J; Wang D; Kong P; Wang Z; Liu Y
    Crit Rev Microbiol; 2024 May; 50(3):267-284. PubMed ID: 36890767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro antimicrobial activity of propolis and synergism between propolis and antimicrobial drugs.
    Stepanović S; Antić N; Dakić I; Svabić-Vlahović M
    Microbiol Res; 2003; 158(4):353-7. PubMed ID: 14717457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel Antibacterial Compounds and their Drug Targets - Successes and Challenges.
    Kaczor AA; Polski A; Sobótka-Polska K; Pachuta-Stec A; Makarska-Bialokoz M; Pitucha M
    Curr Med Chem; 2017; 24(18):1948-1982. PubMed ID: 27978802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal of antibiotic resistance in Gram-positive bacteria by the antihistaminic azelastine.
    El-Nakeeb MA; Abou-Shleib HM; Khalil AM; Omar HG; El-Halfawy OM
    APMIS; 2012 Mar; 120(3):215-20. PubMed ID: 22339679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.